Since RAD51 participates in DNA repair, while also interacting with BRCA proteins, the mutations of which are often identified in ovarian cancer, the above-mentioned polymorphisms may be associated with a higher risk of this cancer development [42, 43]. This evidence concerns the gene RAD51 and ovarian cancer.